
An Israeli biotech company that develops medical products based on cannabis and fungal extracts, Cannabotech reported Tuesday cell model study results showing that its "Integrative-Colon" products killed over 90% of colon cancer cells. The Integrative-Colon products are based on a combination of several cannabinoids from the cannabis plant and various mushroom extracts.